ClinicalTrials.gg
RecruitingNCT07146373Updated Aug 28, 2025

Effect of Inspiratory Muscle Training in Cognition

An interventional study of Inspiratoty Muscle training and Usual Care in Mild Cognitive Impairment (MCI), sponsored by University of West Attica. Recruiting at 1 site in Greece. Open to participants aged 60 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-08-28.

Sponsored by University of West Attica · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Mar 2025, registered Aug 2025).
  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
60 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Cognitive Dysfunction with a site in Greece — 15 open to participants now, 17 under way, 2 of them phase 3. Cognitive Dysfunction · Greece.

Planned enrollment
18th of 22
76 · median 150
Started
2025
with 11 others
No phase
17 of 29
8 open now
Primary completion
2027-12
later than 9 of 16 live
Registered
21st of 29
by date

Among the 29 studies in Cognitive Dysfunction with a site in Greece, this one is the 18th largest by planned enrollment of the 22 interventional ones that give a count, is one of 12 that started in 2025, is one of 17 with no phase, reaches primary completion later than 9 of the 16 other live ones, and was the 21st registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

15 of the 29 studies in Cognitive Dysfunction with a site in Greece are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in Greece have not opened yet or have stopped. Only those recruiting at a site in Greece →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 60 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Cognitive Dysfunction with a site in Greece, or all of them as a file.
02

Study summary

The goal of this clinical trial is to examine the effect of a respiratory muscle strengthening program on the cognitive and physical functioning of patients with neurocognitive disorders (Mild Cognitive Impairment) or those predisposed to them.

The main questions that aims to answer are:

  1. Is Inpsiratory Muscle Training (IMT) feasible in people with mild cognitive impairement?
  2. Could Inspiratory Muscle Training (IMT) improve congitive function in people with mild cognitive impairement?
  3. Could Inspiratory Musclre training improve physical function in this population?

Participants will be:

  1. \< 60 age or > 90 age
  2. MMSE (Mini Mental State Examination) score ≤ 28 and ≥ 18 and follow a high intensity IMT program along with a physical - cognitive program. or just the physical - cognitive program.
03

Conditions studied

  • Mild Cognitive Impairment (MCI)

Keywords

  • mild cognitive impairement
  • dementia
  • respiratory physiotherapy
  • inspiratory muscle training
04

Who can participate

Ages eligible
60 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (Mini Mental State Examination) score ≤ 28 και ≥ 18
  • stable treatment related to medication

Exclusion criteria

Exclusion Criteria:

  • score \< 18 και > 28
  • psychological disorder
  • any to physical training
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    Inspiratory Muscle Training

    IMT that consists of 5set/6 breaths at 50-60% of Maximal Inspiratory Pressure, 5 session per weak for 3 months. Physical and Cognitive training

    Other: Inspiratoty Muscle training

  • Active comparator
    Control

    Physical and cognitive training

    Other: Usual Care

Interventions

  • OtherInspiratoty Muscle training

    Participants will follow an IMT program through a threshold IMT device which consists of 5 set/6 breaths at 50-60% MIP for 3 months along with their usual physical and cogntive training

  • OtherUsual Care

    Physical and cognitive training

06

What researchers measure

Primary outcomes

  1. Mini Mental State Examination

    Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)

Secondary outcomes

  1. Frontal Assessment Battery

    Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)

  2. Addenbrooke's Cognitive Examination

    Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)

  3. Time up and Go (TUG)

    Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)

  4. Sit-to-Stand test

    Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Dec 2027, 33 months after the start.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 33 months is above that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2025
First posted
Aug 28, 2025
StartActual
Mar 1, 2025
Primary completionEst.
Dec 30, 2027
CompletionEst.
May 30, 2028
Last update
Aug 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07146373
Lead sponsor
University of West Attica
Responsible party
IRINI PATSAKI (Assistant Professor, University of West Attica) — Principal investigator
First posted
Aug 28, 2025
Start date
Mar 1, 2025
Primary completion
Dec 30, 2027 (estimated)
Completion
May 30, 2028 (estimated)
Last update
Aug 28, 2025

Study contacts

IRINI PATSAKI, PhD
Contact
ipatsaki@uniwa.gr
+306942064363
Theodoros Zekis, MSc
Contact
tzekis@uniwa.gr
+306942064363
IRINI PATSAKI, PhD
principal investigator · University of West Attica

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion